molsidomine has been researched along with dibutyryl cyclic gmp in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alam, AS; Datta, HK; Hecker, M; Lidbury, PS; MacIntyre, I; Moonga, BS; Vane, JR; Zaidi, M | 1 |
Alanko, J; Mucha, I; Riutta, A; Vapaatalo, H | 1 |
Madison, DV; Meffert, MK; Schulman, H; Schuman, EM | 1 |
Hess, DT; Patterson, SI; Skene, JH; Smith, DS | 1 |
Barkin, M; Barnett, CC; Moore, EE; Offner, PJ; Partrick, DA; Silliman, CC | 1 |
Corriveau, CC; Danner, RL; Madara, PJ; Tropea, MM; Van Dervort, AL; Wesley, RA | 1 |
6 other study(ies) available for molsidomine and dibutyryl cyclic gmp
Article | Year |
---|---|
Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.
Topics: Animals; Animals, Newborn; Bone Resorption; Calcitonin; Calcium; Cell Membrane; Cells, Cultured; Cyclic GMP; Cytosol; Dibutyryl Cyclic GMP; Ionomycin; Kinetics; Molsidomine; Nitric Oxide; Osteoclasts; Rats; Rats, Inbred Strains; Vasodilator Agents | 1991 |
Effects of Trolox C and SIN-1 on arachidonic acid metabolism and on cyclic GMP formation in leukocytes.
Topics: Antioxidants; Arachidonic Acid; Calcimycin; Centrifugation, Density Gradient; Chromans; Cyclic GMP; Dibutyryl Cyclic GMP; Dinoprostone; Dose-Response Relationship, Drug; Guanylate Cyclase; Humans; Leukotriene B4; Molsidomine; Neutrophils; Radioimmunoassay; Vasodilator Agents; Vitamin E | 1994 |
An ADP-ribosyltransferase as a potential target for nitric oxide action in hippocampal long-term potentiation.
Topics: 2-Amino-5-phosphonovalerate; Animals; Cyclic GMP; Dibutyryl Cyclic GMP; Evoked Potentials; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Molsidomine; N-Methylaspartate; NAD; Niacinamide; Nitric Oxide; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 1994 |
Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxide.
Topics: Acylation; Animals; Cells, Cultured; Cyclic GMP; Dibutyryl Cyclic GMP; Ganglia, Spinal; Hemoglobins; Molsidomine; Nerve Crush; Nerve Tissue Proteins; Neurites; Neurons; Nitric Oxide; Palmitic Acid; Palmitic Acids; PC12 Cells; Rats; Sciatic Nerve; Time Factors; Vasodilator Agents | 1993 |
Nitric oxide attenuates platelet-activating factor priming for elastase release in human neutrophils via a cyclic guanosine monophosphate-dependent pathway.
Topics: Adult; Analysis of Variance; Cyclic GMP; Dibutyryl Cyclic GMP; Humans; In Vitro Techniques; Kinetics; Leukocyte Elastase; Models, Biological; Molsidomine; Neutrophils; Nitric Oxide; Platelet Activating Factor; Signal Transduction; Substrate Specificity | 1997 |
Effects of nitric oxide on chemotaxis and endotoxin-induced interleukin-8 production in human neutrophils.
Topics: Acetylcysteine; Cells, Cultured; Chemotaxis; Complement C5a; Cyclic GMP; Dibutyryl Cyclic GMP; Dose-Response Relationship, Drug; Ferricyanides; Glutathione; Humans; Interleukin-8; Leukotriene B4; Lipopolysaccharides; Molsidomine; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Nitroso Compounds; omega-N-Methylarginine; RNA, Messenger; S-Nitrosoglutathione; Up-Regulation | 1998 |